Obermatt
See Similar Stocks →

CVS Group

LSE:CVSG · GB00B2863827
Health Care Providers & ServicesMedium

360

79
EV / EBIT81
Price / Owner Earnings58
Owner Earnings Yield83
Dividend Yield47
Price/Sales51
EV / Gross Profit82
Price/Book35
Return on Capital59
Cash Return on Capital88
Return on Equity32
EBIT Margin31
Gross Profitability91
Cash Conversion44
Accruals50
Owner Earnings Margin77
Sales growth67
Profit Growth50
Long-Term EPS Growth60
Owner Earnings Growth36
Reinvestment58
Price momentum47
Debt load43
Refinancing40
Debt Payback65
Liquidity49
Analyst ratings56
Opinion Changes50
Price Target Upside70
Market mood13
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

CVS Group clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUK
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeLSE
Founded2007
Employees972
Websitecvsukltd.co.uk
ISINGB00B2863827
Last UpdateApr 2, 2026
Index & Theme
Pet CarePet Food and SuppliesHealth DiagnosticsHealth CareVeterinary

Description

CVS Group plc operates as a provider of veterinary services, offering a comprehensive array of animal healthcare solutions. Business Segments The company’s operations are organized into four primary segments: Veterinary Practices, Laboratories, Cre…

Analysis

Middle-of-the-road

CVS Group plc sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is attractive. The owner-earnings multiple stands at 12.4×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around -0% a year, against analyst forecasts of 9%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is adequate. The company scores 10/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
79
2023202420252026

All-time high

83

Mar 2026

All-time low

9

Jan 2025

Average rank

45

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
51
57
51
58
Price/Earnings
58
78
57
52
Price/Book
35
41
12
28
Dividend Yield
47
47
30
35
Value (overall)
41
52
28
39

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare CVS Group with its peers
Medicover
STO:MCOV B
21
CountryCyprus
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
DiaSorin
MIL:DIA
34
CountryItaly
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
bioMerieux
PAR:BIM
72
CountryFrance
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Uniphar
ISE:UPR
59
CountryIreland
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Philips
AEX:PHIA
71
CountryNetherlands
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
EssilorLuxottica
PAR:EL
55
CountryFrance
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →